vs
ASSOCIATED BANC-CORP（ASB）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是ASSOCIATED BANC-CORP的1.6倍（$622.0M vs $383.0M），Royalty Pharma plc净利率更高（34.4% vs 31.2%，领先3.2%），过去两年ASSOCIATED BANC-CORP的营收复合增速更高（9.1% vs 4.6%）
联合银行集团（Associated Banc-Corp）是美国区域性银行控股公司，总部位于威斯康星州格林贝，深耕美国中西部地区，主营零售银行、商业银行、商业地产贷款、私人银行及特色金融服务，在威斯康星州、伊利诺伊州、明尼苏达州设有220多个营业网点，覆盖100多个社区，还在印第安纳、密歇根等多州设有贷款办事处。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ASB vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.6倍
$383.0M
净利率更高
RPRX
高出3.2%
31.2%
两年增速更快
ASB
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $383.0M | $622.0M |
| 净利润 | $119.6M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 31.2% | 34.4% |
| 营收同比 | — | 4.8% |
| 净利润同比 | 566.6% | 2.9% |
| 每股收益（稀释后） | $0.70 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASBRPRX
| Q1 26 | $383.0M | — | ||
| Q4 25 | $310.0M | $622.0M | ||
| Q3 25 | $305.2M | $609.3M | ||
| Q2 25 | $300.0M | $578.7M | ||
| Q1 25 | $285.9M | $568.2M | ||
| Q4 24 | $270.3M | $593.6M | ||
| Q3 24 | $329.7M | $564.7M | ||
| Q2 24 | $321.8M | $537.3M |
净利润ASBRPRX
| Q1 26 | $119.6M | — | ||
| Q4 25 | $137.1M | $214.2M | ||
| Q3 25 | $124.7M | $288.2M | ||
| Q2 25 | $111.2M | $30.2M | ||
| Q1 25 | $101.7M | $238.3M | ||
| Q4 24 | $-161.6M | $208.2M | ||
| Q3 24 | $88.0M | $544.0M | ||
| Q2 24 | $115.6M | $102.0M |
营业利润率ASBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 52.6% | 62.4% | ||
| Q3 25 | 50.5% | 70.1% | ||
| Q2 25 | 46.5% | 36.3% | ||
| Q1 25 | 42.3% | 94.0% | ||
| Q4 24 | -65.8% | 60.9% | ||
| Q3 24 | 32.8% | — | ||
| Q2 24 | 32.0% | 50.2% |
净利率ASBRPRX
| Q1 26 | 31.2% | — | ||
| Q4 25 | 44.2% | 34.4% | ||
| Q3 25 | 40.9% | 47.3% | ||
| Q2 25 | 37.1% | 5.2% | ||
| Q1 25 | 35.6% | 41.9% | ||
| Q4 24 | -59.8% | 35.1% | ||
| Q3 24 | 26.7% | 96.3% | ||
| Q2 24 | 35.9% | 19.0% |
每股收益（稀释后）ASBRPRX
| Q1 26 | $0.70 | — | ||
| Q4 25 | $0.80 | $0.49 | ||
| Q3 25 | $0.73 | $0.67 | ||
| Q2 25 | $0.65 | $0.07 | ||
| Q1 25 | $0.59 | $0.55 | ||
| Q4 24 | $-1.10 | $0.46 | ||
| Q3 24 | $0.56 | $1.21 | ||
| Q2 24 | $0.74 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $5.0B | $9.7B |
| 总资产 | $45.6B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ASBRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B |
总债务ASBRPRX
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $9.0B | ||
| Q3 25 | $594.1M | $8.9B | ||
| Q2 25 | $593.5M | $8.0B | ||
| Q1 25 | $591.4M | $7.6B | ||
| Q4 24 | $1.4B | $7.6B | ||
| Q3 24 | $844.3M | $7.6B | ||
| Q2 24 | $536.1M | $7.6B |
股东权益ASBRPRX
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | $9.7B | ||
| Q3 25 | $4.9B | $9.6B | ||
| Q2 25 | $4.8B | $9.5B | ||
| Q1 25 | $4.7B | $9.8B | ||
| Q4 24 | $4.6B | $10.3B | ||
| Q3 24 | $4.4B | $10.3B | ||
| Q2 24 | $4.2B | $9.8B |
总资产ASBRPRX
| Q1 26 | $45.6B | — | ||
| Q4 25 | $45.2B | $19.6B | ||
| Q3 25 | $44.5B | $19.3B | ||
| Q2 25 | $44.0B | $18.3B | ||
| Q1 25 | $43.3B | $17.6B | ||
| Q4 24 | $43.0B | $18.2B | ||
| Q3 24 | $42.2B | $18.0B | ||
| Q2 24 | $41.6B | $17.7B |
负债/权益比ASBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.20× | 0.92× | ||
| Q3 25 | 0.12× | 0.93× | ||
| Q2 25 | 0.12× | 0.84× | ||
| Q1 25 | 0.13× | 0.78× | ||
| Q4 24 | 0.31× | 0.74× | ||
| Q3 24 | 0.19× | 0.74× | ||
| Q2 24 | 0.13× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASBRPRX
| Q1 26 | — | — | ||
| Q4 25 | $218.1M | $827.1M | ||
| Q3 25 | $158.0M | $702.6M | ||
| Q2 25 | $141.5M | $364.0M | ||
| Q1 25 | $98.2M | $596.1M | ||
| Q4 24 | $207.1M | $742.5M | ||
| Q3 24 | $105.1M | $703.6M | ||
| Q2 24 | $113.5M | $658.2M |
现金转化率ASBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 1.59× | 3.86× | ||
| Q3 25 | 1.27× | 2.44× | ||
| Q2 25 | 1.27× | 12.06× | ||
| Q1 25 | 0.97× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 1.19× | 1.29× | ||
| Q2 24 | 0.98× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASB
| Net Interest Income | $307.2M | 80% |
| Noninterest Income | $75.9M | 20% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
